Board of Pharmacy Virtual Meeting
-
Thursday, 10/20/2022 -
Time: 09:00 AM
Recurring:
Event status: Handicap access, ADA Contact info: James Skizewski,(808) 586-2697(808) 586-2697, pharmacy@dcca.hawaii.gov
Calendar: Board of Pharmacy
Title: Board of Pharmacy Virtual Meeting
Location: Virtual Videoconference Meeting: Zoom Webinar and In-Person Location: Queen Liliuokalani Conference Room, King Kalakaua Building, 335 Merchant Street, 1st Floor, Honolulu, HI 96813
Posted on: 10/13/2022 08:44 AM
Updated on: 10/13/2022 09:51 AM
Board of Pharmacy
- Date:
- Thursday, 10/20/2022
- Start Time:
- 09:00 AM
- Place:
-
Virtual Videoconference Meeting: Zoom Webinar and In-Person Location: Queen Liliuokalani Conference Room, King Kalakaua Building, 335 Merchant Street, 1st Floor, Honolulu, HI 96813
Agenda
BOARD OF PHARMACY
Professional and Vocational Licensing Division
Department of Commerce and Consumer Affairs
State of Hawaii
AGENDA
Date: Thursday, October 20, 2022
Time: 9:00 a.m.
In-Person Queen Liliuokalani Conference Room
Meeting King Kalakaua Building, 1st Floor
Location: 335 Merchant Street
Honolulu, Hawaii 96813
Agenda: The agenda was posted to the State electronic calendar as required
by Hawaii Revised Statutes (“HRS”) section 92-7(b).
Virtual Virtual Videoconference Meeting – Zoom Webinar (use link below)
Participation: https://dcca-hawaii-gov.zoom.us/j/99443780976
Phone: (669) 900-6833
Meeting ID: 994 4378 0976
In light of the COVID-19 pandemic, protecting the health and safety of the community is of utmost concern. If you wish to submit written testimony on any agenda item, please email your testimony to pharmacy@dcca.hawaii.gov by hard copy mail to Attn: Board of Pharmacy Board, P.O. Box 3469, Honolulu, HI 96801. Testimony must be received at least 24 hours prior to the meeting to ensure that it can be distributed to the Board members.
To view the meeting and provide live oral testimony, please use the link at the top of the agenda. You will be asked to enter your name. The Board requests that you enter your full name, but you may use a pseudonym or other identifier if you wish to remain anonymous. You will also be asked for an email address. You may fill in this field with any entry in an email format, e.g., *****@***mail.com.
Your microphone will be automatically muted. When the Chairperson asks for public testimony, you may click the Raise Hand button found on your Zoom screen to indicate that you wish to testify about that agenda item. The Chairperson will individually enable each testifier to unmute their microphone. When recognized by the Chairperson, please unmute your microphone before speaking and mute your microphone after you finish speaking.
PHONE ACCESS:
If you cannot get internet access, you may get audio-only access by calling the phone number listed at the top on the agenda.
Upon dialing the number, you will be prompted to enter the Meeting ID which is also listed at the top of the agenda. After entering the Meeting ID, you will be asked to either enter your panelist number or wait to be admitted into the meeting. You will not have a panelist number. So, please wait until you are admitted into the meeting.
When the Chairperson asks for public testimony, you may indicate you want to testify by entering “#” and then “9” on your phone’s keypad. After entering “#” and then “9”, a voice prompt will let you know that the host of the meeting has been notified. When recognized by the Chairperson, you may unmute yourself by pressing “#” and then “6” on your phone. A voice prompt will let you know that you are unmuted. Once you are finished speaking, please enter “#” and then “6” again to mute yourself.
For both internet and phone access, when testifying, you will be asked to identify yourself and the organization, if any, that you represent. Each testifier will be limited to five minutes of testimony per agenda item.
Instructions to attend State of Hawaii virtual board meetings may be found online at https://cca.hawaii.gov/pvl/files/2020/08/State-of-Hawaii-Virtual-Board-Attendee-Instructions.pdf.
1. Call to Order, Public Notice, Quorum – HRS §92-3 Open Meetings and HAR §16-89-70 Oral Testimony
2. Chair’s Report
a. Announcements
b. Approval of Minutes of July 14, 2022
3. Executive Officer Report
a. Correspondence
1) Pharmacy Technician Licensing
2) USP General Chapter 825
b. Hawaii Pharmacists Associations
c. Daniel K. Inouye College of Pharmacy Interim Dean Introduction
4. Board Business
a. Creation of a Permitted Interaction Group (PIG) related to Pharmacy Miscellaneous Permits
5. Applications (The Board may move into Executive Session in accordance with HRS §92-4 and §92-5(a)(1)
and (4) “To consider and evaluate personal information relating to individuals applying for licensure;” and
“To consult with the Board’s attorney on questions and issues pertaining to the Board’s powers, duties,
privileges, immunities, and liabilities;”, Board will vote in Open Meeting.)
a. Ratification List
b. Applications
1) Miscellaneous Permit
i. Everwell Specialty Pharmacy, LLC
ii. Curexa East II, LLC
iii. Boothwyn Pharmacy
2) Pharmacist
i. Ehab Attia
6. Chapter 91, HRS – Adjudicatory Matters
a. In the Matter of the Miscellaneous Permits of Tabula Rasa Healthcare Group, Inc., dba MedwiseRx; PHA 2022-29-L and PHA 2022-31-L, Settlement Agreement Prior to Filing of Petition for Disciplinary Action and Board’s Final Order; Exhibits “1” – “2”
b. In the Matter of the Miscellaneous Permits of Vertisis Custom Pharmacy; PHA 2022-17-L, Settlement Agreement Prior to Filing of Petition for Disciplinary Action and Board’s Final Order; Exhibit “1”
7. Next Meeting: December 15, 2022
9:00 a.m.
Virtual
8. Adjournment
If you need an auxiliary aid/service or other accommodation due to a disability, contact James Skizewski at (808)586-2697 and pharmacy@dcca.hawaii.gov of the Board of Pharmacy as soon as possible, preferably two (2) business days prior to the meeting. If a response is received after that date, we will try to obtain the auxiliary aid/service or accommodation, but we cannot guarantee that the request will be fulfilled.
Upon request, this notice is available in alternate formats such as large print, Braille, or electronic copy.
10/12/2022
Attachments: